{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:40:59Z","timestamp":1791243659308,"version":"4.1.0"},"reference-count":39,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mechanisms involving the in vitro effect of rituximab in cells from 55 patients with B-cell lymphoproliferative disorders were investigated. No cytotoxic effect was observed when cells were incubated with rituximab alone, but in the presence of human AB serum rituximab induced complement-dependent cell death (R-CDC). A cytotoxic effect was observed in cells from 9 of 33 patients with B-cell chronic lymphocytic leukemia, 16 of 16 patients with mantle-cell lymphoma, 4 of 4 patients with follicular lymphoma, and 2 of 2 patients with hairy-cell leukemia. R-CDC was observed in cells from patients expressing more than 50\u2009\u00d7\u2009103 CD20 molecules per cell, and directly correlated with the number of CD20 molecules per cell. Preincubation with anti-CD59 increased the cytotoxic effect of rituximab and sensitized cells from nonsensitive cases. Neither cleavage of poly-ADP ribose polymerase (PARP) nor activation of caspase-3 was observed in R-CDC. In addition, no cells with a hypodiploid DNA content were detected and R-CDC was not prevented by a broad-spectrum caspase inhibitor, suggesting a caspase-independent mechanism. Incubation with rituximab in the presence of AB serum induced a rapid and intense production of reactive oxygen species (ROS). R-CDC was blocked by the incubation of cells with N-acetyl-L-cysteine (NAC) or Tiron, 2 ROS scavengers, indicating that the cytotoxic effect was due to the generation of superoxide (O2\u2212) radicals. In conclusion, the results of the present study suggest that CD20, CD59, and complement have a role in the in vitro cytotoxic effect of rituximab, which is mediated by a caspase-independent process that involves ROS generation.<\/jats:p>","DOI":"10.1182\/blood.v98.9.2771","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:47Z","timestamp":1027774007000},"page":"2771-2777","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":167,"title":["Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species"],"prefix":"10.1182","volume":"98","author":[{"given":"Beatriz","family":"Bellosillo","sequence":"first","affiliation":[{"name":"From the Hematopathology Unit, Department of Hematology, Institute of Hematology and Oncology, Department of Pathology, Postgraduate School of Hematology Farreras-Valent\u0131\u0301; the Institut d'Investigacions Biome\u0300diques August Pi i Sunyer (IDIBAPS), Hospital Cl\u0131\u0301nic; and the University of Barcelona, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Villamor","sequence":"additional","affiliation":[{"name":"From the Hematopathology Unit, Department of Hematology, Institute of Hematology and Oncology, Department of Pathology, Postgraduate School of Hematology Farreras-Valent\u0131\u0301; the Institut d'Investigacions Biome\u0300diques August Pi i Sunyer (IDIBAPS), Hospital Cl\u0131\u0301nic; and the University of Barcelona, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Lo\u0301pez-Guillermo","sequence":"additional","affiliation":[{"name":"From the Hematopathology Unit, Department of Hematology, Institute of Hematology and Oncology, Department of Pathology, Postgraduate School of Hematology Farreras-Valent\u0131\u0301; the Institut d'Investigacions Biome\u0300diques August Pi i Sunyer (IDIBAPS), Hospital Cl\u0131\u0301nic; and the University of Barcelona, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Marce\u0301","sequence":"additional","affiliation":[{"name":"From the Hematopathology Unit, Department of Hematology, Institute of Hematology and Oncology, Department of Pathology, Postgraduate School of Hematology Farreras-Valent\u0131\u0301; the Institut d'Investigacions Biome\u0300diques August Pi i Sunyer (IDIBAPS), Hospital Cl\u0131\u0301nic; and the University of Barcelona, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Esteve","sequence":"additional","affiliation":[{"name":"From the Hematopathology Unit, Department of Hematology, Institute of Hematology and Oncology, Department of Pathology, Postgraduate School of Hematology Farreras-Valent\u0131\u0301; the Institut d'Investigacions Biome\u0300diques August Pi i Sunyer (IDIBAPS), Hospital Cl\u0131\u0301nic; and the University of Barcelona, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[{"name":"From the Hematopathology Unit, Department of Hematology, Institute of Hematology and Oncology, Department of Pathology, Postgraduate School of Hematology Farreras-Valent\u0131\u0301; the Institut d'Investigacions Biome\u0300diques August Pi i Sunyer (IDIBAPS), Hospital Cl\u0131\u0301nic; and the University of Barcelona, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Colomer","sequence":"additional","affiliation":[{"name":"From the Hematopathology Unit, Department of Hematology, Institute of Hematology and Oncology, Department of Pathology, Postgraduate School of Hematology Farreras-Valent\u0131\u0301; the Institut d'Investigacions Biome\u0300diques August Pi i Sunyer (IDIBAPS), Hospital Cl\u0131\u0301nic; and the University of Barcelona, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emili","family":"Montserrat","sequence":"additional","affiliation":[{"name":"From the Hematopathology Unit, Department of Hematology, Institute of Hematology and Oncology, Department of Pathology, Postgraduate School of Hematology Farreras-Valent\u0131\u0301; the Institut d'Investigacions Biome\u0300diques August Pi i Sunyer (IDIBAPS), Hospital Cl\u0131\u0301nic; and the University of Barcelona, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019112007031213000_B1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.","volume":"83","author":"Reff","year":"1994","journal-title":"Blood."},{"key":"2019112007031213000_B2","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol."},{"key":"2019112007031213000_B3","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood.V95.10.3052.010k30_3052_3056","article-title":"Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma.","volume":"95","author":"Hainsworth","year":"2000","journal-title":"Blood."},{"key":"2019112007031213000_B4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.1999.17.1.268","article-title":"Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.","volume":"17","author":"Czuczman","year":"1999","journal-title":"J Clin Oncol."},{"key":"2019112007031213000_B5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1200\/JCO.2000.18.2.317","article-title":"European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.","volume":"18","author":"Foran","year":"2000","journal-title":"J Clin Oncol."},{"key":"2019112007031213000_B6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/11.suppl_1.S117","article-title":"Treatment of mantle-cell lymphoma with rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response.","volume":"11(suppl 1)","author":"Foran","year":"2000","journal-title":"Ann Oncol."},{"key":"2019112007031213000_B7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1365-3083.2000.00745.x","article-title":"Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms.","volume":"51","author":"Harjunpaa","year":"2000","journal-title":"Scand J Immunol."},{"key":"2019112007031213000_B8","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood.V91.5.1644.1644_1644_1652","article-title":"Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies.","volume":"91","author":"Shan","year":"1998","journal-title":"Blood."},{"key":"2019112007031213000_B9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/bcmd.2000.0287","article-title":"Clustered CD20 induced apoptosis: Src-family kinase, the proximal regulator of tyrosine phosphorylation, calcium influx, and caspase 3-dependent apoptosis.","volume":"26","author":"Hofmeister","year":"2000","journal-title":"Blood Cells Mol Dis."},{"key":"2019112007031213000_B10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0167-5699(99)01537-6","article-title":"Immune evasion of tumor cells using membrane-bound complement regulatory proteins.","volume":"20","author":"Gorter","year":"1999","journal-title":"Immunol Today."},{"key":"2019112007031213000_B11","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1182\/blood.V95.12.3900","article-title":"Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis.","volume":"95","author":"Golay","year":"2000","journal-title":"Blood."},{"key":"2019112007031213000_B12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","article-title":"The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.","volume":"10","author":"Harris","year":"1999","journal-title":"Ann Oncol."},{"key":"2019112007031213000_B13","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood.V94.8.2836.420k35_2836_2843","article-title":"In vitro evaluation of fludarabine in combination with cyclophosphamide and\/or mitoxantrone in B-cell chronic lymphocytic leukemia.","volume":"94","author":"Bellosillo","year":"1999","journal-title":"Blood."},{"key":"2019112007031213000_B14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J Immunol Methods."},{"key":"2019112007031213000_B15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0968-0004(96)20008-8","article-title":"Reactive oxygen species and programmed cell death.","volume":"21","author":"Jacobson","year":"1996","journal-title":"Trends Biochem Sci."},{"key":"2019112007031213000_B16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/niox.1997.0143","article-title":"DNA damage induced by peroxynitrite: subsequent biological effects.","volume":"1","author":"Szabo","year":"1997","journal-title":"Nitric Oxide."},{"key":"2019112007031213000_B17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0891-5849(96)00275-4","article-title":"Oxidants as stimulators of signal transduction.","volume":"22","author":"Suzuki","year":"1997","journal-title":"Free Radic Biol Med."},{"key":"2019112007031213000_B18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1083\/jcb.141.6.1423","article-title":"The regulation of reactive oxygen species production during programmed cell death.","volume":"141","author":"Tan","year":"1998","journal-title":"J Cell Biol."},{"key":"2019112007031213000_B19","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.1073\/pnas.91.23.10771","article-title":"Oxidative damage and mitochondrial decay in aging.","volume":"91","author":"Shigenaga","year":"1994","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019112007031213000_B20","first-page":"11","article-title":"Reactive oxygen species and the neurodegenerative disorders.","volume":"27","author":"Knight","year":"1997","journal-title":"Ann Clin Lab Sci."},{"key":"2019112007031213000_B21","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","article-title":"Reactive oxygen species and the central nervous system.","volume":"59","author":"Halliwell","year":"1992","journal-title":"J Neurochem."},{"key":"2019112007031213000_B22","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.1073\/pnas.90.17.7915","article-title":"Oxidants, antioxidants, and the degenerative diseases of aging.","volume":"90","author":"Ames","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019112007031213000_B23","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/35030140","article-title":"Superoxide dismutase as a target for the selective killing of cancer cells.","volume":"407","author":"Huang","year":"2000","journal-title":"Nature."},{"key":"2019112007031213000_B24","doi-asserted-by":"crossref","first-page":"12684","DOI":"10.1074\/jbc.275.17.12684","article-title":"Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumor necrosis factor-alpha-induced apoptosis of rat mesangial cells.","volume":"275","author":"Moreno-Manzano","year":"2000","journal-title":"J Biol Chem."},{"key":"2019112007031213000_B25","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.4049\/jimmunol.159.10.4762","article-title":"CD4+CD8+ thymocytes are preferentially induced to die following CD45 cross-linking, through a novel apoptotic pathway.","volume":"159","author":"Lesage","year":"1997","journal-title":"J Immunol."},{"key":"2019112007031213000_B26","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.4049\/jimmunol.161.7.3375","article-title":"Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes.","volume":"161","author":"Deas","year":"1998","journal-title":"J Immunol."},{"key":"2019112007031213000_B27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/15233","article-title":"CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia.","volume":"5","author":"Mateo","year":"1999","journal-title":"Nat Med."},{"key":"2019112007031213000_B28","doi-asserted-by":"crossref","first-page":"14559","DOI":"10.1073\/pnas.93.25.14559","article-title":"BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases.","volume":"93","author":"Xiang","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019112007031213000_B29","doi-asserted-by":"crossref","first-page":"11401","DOI":"10.1074\/jbc.273.19.11401","article-title":"Superoxide in apoptosis: mitochondrial generation triggered by cytochrome c loss.","volume":"273","author":"Cai","year":"1998","journal-title":"J Biol Chem."},{"key":"2019112007031213000_B30","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1038\/sj.onc.1203249","article-title":"More than one way to die: apoptosis, necrosis and reactive oxygen damage.","volume":"18","author":"Fiers","year":"1999","journal-title":"Oncogene."},{"key":"2019112007031213000_B31","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.4049\/jimmunol.161.12.6689","article-title":"Redox regulation of caspase-3(-like) protease activity: regulatory roles of thioredoxin and cytochrome c.","volume":"161","author":"Ueda","year":"1998","journal-title":"J Immunol."},{"key":"2019112007031213000_B32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0378-4274(98)00333-6","article-title":"Redox regulation of apoptotic cell death in the immune system.","volume":"102-103","author":"Hampton","year":"1998","journal-title":"Toxicol Lett."},{"key":"2019112007031213000_B33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s002620050016","article-title":"Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells.","volume":"48","author":"Shan","year":"2000","journal-title":"Cancer Immunol Immunother."},{"key":"2019112007031213000_B34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0037-1963(00)90055-6","article-title":"Apoptosis and cancer: strategies for integrating programmed cell death.","volume":"37(suppl 7)","author":"Reed","year":"2000","journal-title":"Semin Hematol."},{"key":"2019112007031213000_B35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/13684730050515804","article-title":"Effect of interferon-alpha on CD20 antigen expression of B-cell chronic lymphocytic leukemia.","volume":"6","author":"Sivaraman","year":"2000","journal-title":"Cytokines Cell Mol Ther."},{"key":"2019112007031213000_B36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0145-2126(99)00206-4","article-title":"Effects of cytokines on CD20 antigen expression on tumor cells from patients with chronic lymphocytic leukemia.","volume":"24","author":"Venugopal","year":"2000","journal-title":"Leuk Res."},{"key":"2019112007031213000_B37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/annonc\/11.suppl_1.S107","article-title":"Treatment of multiple myeloma by antibody mediated immunotherapy and induction of myeloma selective antigens.","volume":"11(suppl 1)","author":"Treon","year":"2000","journal-title":"Ann Oncol."},{"key":"2019112007031213000_B38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-3083.1995.tb03688.x","article-title":"Down-regulation of CD59 (protectin) expression on human colorectal adenocarcinoma cell lines by levamisole.","volume":"42","author":"Bjorge","year":"1995","journal-title":"Scand J Immunol."},{"key":"2019112007031213000_B39","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1182\/blood.V96.10.3544.h8003544_3544_3552","article-title":"Therapeutic efficacy of Fc\u03b3RI\/CD64-directed bispecific antibodies in B-cell lymphoma.","volume":"96","author":"Honeychurch","year":"2000","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/9\/2771\/1442636\/h8210102771.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/9\/2771\/1442636\/h8210102771.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T20:11:00Z","timestamp":1682280660000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/98\/9\/2771\/53477\/Complementmediated-cell-death-induced-by-rituximab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,1]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,11,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v98.9.2771","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11,1]]}}}